ResMed set to launch travel CPAP

 - 
Tuesday, January 10, 2017

SAN DIEGO – ResMed has received clearance from the U.S. Food and Drug Administration for its AirMini, a device that the company says is “the world’s smallest continuous positive airway pressure (CPAP) device.” ResMed expects to launch the AirMini later this year. It is designed as a secondary CPAP, making it easier for users to continue their sleep therapy while traveling. “ResMed AirMini is the portable travel CPAP patients and home medical equipment providers have been waiting for, and we look forward to bringing it to market later this year,” said ResMed CEO Mick Farrell in a press release. “It fits easily in carry-on luggage—even in the seatback pocket on the plane.” Human Design Capital, which is owned by private investment firm PBM Capital, launched a portable CPAP device called the Z1 in 2013. It is sold direct to consumers.